The successful development of a greatly simplified purification process for recombinant protein is described. The direct chemical extraction of recombinant L1 protein (the major capsid protein of human papillomavirus type 16) from cytoplasmic inclusion bodies in E. coli was demonstrated at high cell density (to OD600 = 80). Highly efficient and selective precipitation of DNA was achieved during extraction using spermine, allowing direct coupling to an immobilized metal affinity column operated in expanded bed mode (IMAC-EBA). Direct capture of the target L1 protein from the extraction broth gave an unoptimized yield of 60% with a purification factor of 10. The demonstrated process greatly simplifies the way in which protein expressed as an ...
Biopharmaceutical and biotechnology businesses use Escherichia coli to make recombinant proteins for...
The efficient in vivo folding of many heterologous proteins is a major bottleneck of high level prod...
The efficient in vivo folding of many heterologous proteins is a major bottleneck of high level prod...
In previous parts of this study we developed procedures for the high-efficiency chemical extraction ...
In previous parts of this study we developed procedures for the high-efficiency chemical extraction ...
The direct chemical extraction of recombinant L1 protein (the major capsid protein of human papillom...
A method is presented for the direct extraction of the recombinant protein Long-R3-IGF-I from inclus...
A method is presented for the direct extraction of the recombinant protein Long-R-3-IGF-I from inclu...
The production of recombinant proteins in Escherichia coli often leads to the formation of an intrac...
The major capsid protein L1 of the human papillomavirus type 16 (HPV16) has been previously expresse...
The production of recombinant proteins in the microbial host Escherichia coli often results in the f...
Biopharmaceutical industries have been exploiting microbial organisms such as Escherichia coli to ma...
Volumetric protein production yields in Escherichia coli fermentations have improved with developmen...
In this study we introduce a radical new approach for the recovery of proteins expressed in the form...
Recombinant DNA technology has allowed the cloning and expression of heterologous proteins in a host...
Biopharmaceutical and biotechnology businesses use Escherichia coli to make recombinant proteins for...
The efficient in vivo folding of many heterologous proteins is a major bottleneck of high level prod...
The efficient in vivo folding of many heterologous proteins is a major bottleneck of high level prod...
In previous parts of this study we developed procedures for the high-efficiency chemical extraction ...
In previous parts of this study we developed procedures for the high-efficiency chemical extraction ...
The direct chemical extraction of recombinant L1 protein (the major capsid protein of human papillom...
A method is presented for the direct extraction of the recombinant protein Long-R3-IGF-I from inclus...
A method is presented for the direct extraction of the recombinant protein Long-R-3-IGF-I from inclu...
The production of recombinant proteins in Escherichia coli often leads to the formation of an intrac...
The major capsid protein L1 of the human papillomavirus type 16 (HPV16) has been previously expresse...
The production of recombinant proteins in the microbial host Escherichia coli often results in the f...
Biopharmaceutical industries have been exploiting microbial organisms such as Escherichia coli to ma...
Volumetric protein production yields in Escherichia coli fermentations have improved with developmen...
In this study we introduce a radical new approach for the recovery of proteins expressed in the form...
Recombinant DNA technology has allowed the cloning and expression of heterologous proteins in a host...
Biopharmaceutical and biotechnology businesses use Escherichia coli to make recombinant proteins for...
The efficient in vivo folding of many heterologous proteins is a major bottleneck of high level prod...
The efficient in vivo folding of many heterologous proteins is a major bottleneck of high level prod...